Armistice Capital, LLC Spectrum Pharmaceuticals Inc Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.31 $2.15 Million - $4.32 Million	3,300,000 Added 19.76%	20,000,000 $19.2 Million
Q1 2023 May 15, 2023	SELL	$0.38 - $1.07 $114,000 - $321,000	-300,000 Reduced 1.76%	16,700,000 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $103,680 - $168,480	324,000 Added 1.94%	17,000,000 $6.29 Million
Q3 2022 Nov 14, 2022	SELL	$0.43 - $1.56 $182,320 - $661,440	-424,000 Reduced 2.48%	16,676,000 $7.17 Million
Q1 2022 May 16, 2022	BUY	$0.63 - $1.59 $4.68 Million - $11.8 Million	7,434,244 Added 76.91%	17,100,000 $22.1 Million
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $8.55 Million - $16.3 Million	-6,734,244 Reduced 41.06%	9,665,756 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $11.5 Million - $20.4 Million	5,352,000 Added 48.44%	16,400,000 $35.8 Million
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $1.01 Million - $1.55 Million	348,000 Added 3.25%	11,048,000 $41.4 Million
Q1 2021 May 17, 2021	BUY	$2.9 - $4.09 $3.21 Million - $4.53 Million	1,108,000 Added 11.55%	10,700,000 $34.9 Million
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $6.83 Million - $10.4 Million	2,020,000 Added 26.68%	9,592,000 $32.7 Million
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $22.6 Million - $37.1 Million	7,572,000 New	7,572,000 $30.9 Million
Q2 2019 Aug 14, 2019	SELL	$7.36 - $11.26 $14.2 Million - $21.7 Million	-1,928,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $3.89 Million - $5.07 Million	428,000 Added 28.53%	1,928,000 $20.6 Million
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $9.59 Million - $25.5 Million	1,500,000 New	1,500,000 $13.1 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account